A blood test so sensitive that it can spot a single cancer cell lurking among a billion healthy ones is moving one step closer to being available at your doctor's office, and health care giant Johnson & Johnson is joining forces to bring it to market. Four big cancer centers also will start studies using the experimental test this year.
Read the full story
here.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.